Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Photobiomodulation in the treatment of palmar-plantar erythrodysesthesia: a randomised controlled clinical study protocol

PROTOCOL VERSION: V.2, 27 October 2023. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Registry (NCT05337423).

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors describe a planned randomised, double-blind clinical trial protocol testing photobiomodulation at 630 nm against a sham treatment, both alongside a moisturising cream, to reduce palmar-plantar erythrodysesthesia caused by capecitabine or 5-fluorouracil chemotherapy. The protocol plans to enrol 40 individuals over four weeks, and no results are reported.

Participants
40
Who or what was studied
Individuals receiving capecitabine or 5-fluorouracil chemotherapy who develop palmar-plantar erythrodysesthesia
Wavelengths
630 nm
Limits stated in the abstract
This is a study protocol only, so no outcomes are reported, and the abstract gives no efficacy results.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjopen.bmj.com.

Record from PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
630 nm
Energy density (fluence)
4 J/cm2

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Intention-to-treat analysis, Trial registration, Sham. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies